Michela Cerno
Overview
Explore the profile of Michela Cerno including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
161
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
La Rocca U, Ricci R, Piciocchi A, Barberi W, Oldani E, Dominietto A, et al.
Blood Transfus
. 2025 Feb;
PMID: 39949023
Background: Antibodies directed against donor-specific HLA allele(s)/antigen(s) (DSAs) represent a known risk factor for hematopoietic stem cell transplantation (HSCT) engraftment. Still, the overall management needs to be standardized. Material And...
2.
Pizzano U, Facchin G, Marcon C, Fabris M, Battista M, Cerno M, et al.
Transpl Infect Dis
. 2023 Feb;
25(2):e14003.
PMID: 36748718
Background: Patients undergoing allogeneic stem-cell transplantation (allo-SCT) have reduced responses to vaccines due to immunosuppressive status linked to GvHD prophylaxis and treatment. In our study, we compared humoral responses to...
3.
Facchin G, Savignano C, Battista M, Isola M, De Martino M, Petruzzellis G, et al.
J Clin Med
. 2022 Jul;
11(14).
PMID: 35887878
Background: Cryopreservation of PBSC for allogenic hematopoietic stem cell transplantation (allo-HSCT) was implemented due to the current Coronavirus 2019 pandemic. The impact of match unrelated donor (MUD) graft freezing on...
4.
Picardi A, Sacchi N, Miotti V, Lorentino F, Oldani E, Rambaldi A, et al.
Transplant Cell Ther
. 2021 May;
27(5):406.e1-406.e11.
PMID: 33965179
HLA molecules are important for immunoreactivity in allogeneic hematopoietic stem cell transplantation (HSCT). The Gruppo Italiano Trapianto di Cellule Staminali e Terapie Cellulari, Italian Bone Marrow Donor Registry, and Associazione...
5.
Rosignoli C, Petruzzellis G, Radici V, Facchin G, Girgenti M, Stella R, et al.
J Clin Med
. 2020 Nov;
9(11).
PMID: 33207616
Patients who undergo hematopoietic stem cell transplants (HSCT) are at major risk of (CD) infection (CDI), the most common cause of nosocomial diarrhea. We conducted a retrospective study, which enrolled...
6.
Lorentino F, Sacchi N, Oldani E, Miotti V, Picardi A, Gallina A, et al.
Haematologica
. 2019 Sep;
105(4):e186-e189.
PMID: 31471374
No abstract available.
7.
Patriarca F, Cigana C, Dozzo M, Lazzarotto D, Geromin A, Isola M, et al.
Biol Blood Marrow Transplant
. 2017 Feb;
23(6):1040.
PMID: 28183535
No abstract available.
8.
Candoni A, De Marchi F, Zanini F, Zannier M, Simeone E, Toffoletti E, et al.
Exp Hematol
. 2017 Feb;
49:25-33.
PMID: 28159598
The FMS-like tyrosine kinase 3 (FLT3) mutation in acute myeloid leukemia (AML) is a negative prognostic factor and, in these cases, allogeneic stem cell transplantation (allo-SCT) can represent an important...
9.
Patriarca F, Cigana C, Massimo D, Lazzarotto D, Geromin A, Isola M, et al.
Biol Blood Marrow Transplant
. 2016 Nov;
23(2):333-339.
PMID: 27826061
The objective of this study was to determine risk factors and outcomes of infections by multidrug-resistant gram-negative (MDR GN) bacteria in 241 recipients of hematopoietic stem cell transplantation (HSCT). The...
10.
Damiani D, Tiribelli M, Geromin A, Cerno M, Zanini F, Michelutti A, et al.
Biol Blood Marrow Transplant
. 2016 May;
22(9):1621-1626.
PMID: 27178373
Recent studies have shown that ABGG2 protein overexpression in acute myeloid leukemia (AML) may be associated with poor response to therapy and increased relapse risk. Few data are available in...